Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Analysts are expecting strong growth driven by the robust sales of https://barryoyba591514.tribunablog.com/eli-lilly-s-q3-performance-an-in-depth-look-51309424